xmlui.themes.about.link
Instituto de Investigación Marqués de Valdecilla (IDIVAL): Envíos recientes
Mostrando ítems 121-140 de 950
-
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study
(Oxford University Press, 2024) -
Curative strategy for high-risk smoldering myeloma: carfilzomib, lenalidomide, and dexamethasone (KRd) followed by transplant, KRd consolidation, and Rd maintenance
(American Society of Clinical Oncology by Lippincott Williams & Wilkins with the assistance of Stanford University's HighWire Press, 2024) -
Worldwide distribution of genetic factors related to severity of COVID-19 infection
(Taylor & Francis, 2024) -
External laryngeal tremor in adult-onset Alexander disease: a case report
(S. Karger, 2024) -
Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway
(Cell Press Elsevier, 2024) -
Surgical cavity dilatation after resection of IDH-mutated astrocytoma of the mesial temporal lobe: illustrative cases
(American Association of Neurological Surgeons, 2024) -
Knowledge of the human papillomavirus by social stratification factors
(Lippincott, Williams & Wilkins, 2020) -
Evaluation of google search trends for liver diseases in Europe
(Romanian Society of Gastroenterology, 2024) -
Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity
(Springer Nature, 2024) -
Association of human papillomavirus genotype 16 viral variant and viral load with cervical high-grade intraepithelial lesions
(American Association for Cancer Research, 2019)